Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: ok1day who wrote (86595)	3/6/2000 4:20:00 PM
From: Jenna	Read Replies (2) \| Respond to of 120523

HATH.. was a sell and rebuy, but I missed the lions share of the HATH gain. PARS I held through about 25% of the correction before finally selling and rebuying. EPMN was never more than a 'hold until it explodes' kind of stock.. I persevered with NERX, SYMBA, PARS but I held MATX, AQLA a little too long. When they are so cheap you might as well hold them. I liked MEDX and MDYN the best but honestly I sold my health care mutual funds last days of February because I was disappointed they did not hold some of these more 'exciting' stocks like REGN etc.. How much of MLNM, INCY, AMGN and BGEN can you hold and still have upside? So I opted to play them myself and have been.